{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:04:40Z","timestamp":1787061880106,"version":"build-2736575974"},"update-to":[{"DOI":"10.1007\/s00705-021-04956-9","type":"expression_of_concern","label":"Expression of concern","source":"retraction-watch","updated":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:00Z","timestamp":1627948800000},"record-id":"34202"}],"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00705-021-04956-9","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T05:06:58Z","timestamp":1611551218000},"page":"949-954","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":117,"title":["RETRACTED ARTICLE: Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study"],"prefix":"10.1007","volume":"166","author":[{"given":"Hany M.","family":"Dabbous","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4366-2218","authenticated-orcid":false,"given":"Sherief","family":"Abd-Elsalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal H.","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed F.","family":"Sherief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma F. S.","family":"Ebeid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Samir Abd","family":"El Ghafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaimaa","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elbahnasawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehab","family":"Badawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Awad","family":"Tageldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,25]]},"reference":[{"issue":"8","key":"4956_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu N, Zhang D, Wang W, Li X, Yang B, Song J et al (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 382(8):727\u2013733","journal-title":"N Engl J Med."},{"issue":"2","key":"4956_CR2","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/resp.13196","volume":"23","author":"Y Yin","year":"2018","unstructured":"Yin Y, Wunderink RG (2018) MERS, SARS and other coronaviruses as causes of pneumonia. Respirology 23(2):130\u2013137","journal-title":"Respirology"},{"key":"4956_CR3","volume-title":"Features, evaluation and treatment coronavirus (COVID-19)","author":"M Cascella","year":"2012","unstructured":"Cascella M, Rajnik M, Cuomo A et al (2012) Features, evaluation and treatment coronavirus (COVID-19). StatPearls Publishing, Treasure Island"},{"key":"4956_CR4","doi-asserted-by":"publisher","first-page":"754","DOI":"10.7326\/M20-1334","volume":"172","author":"J Yazdany","year":"2020","unstructured":"Yazdany J, Kim AHJ (2020) Use of hydroxychloroquine and chloroquine during the COVID-19 pandemic: what every clinician should know. Ann Intern Med. 172:754\u2013755","journal-title":"Ann Intern Med."},{"issue":"4","key":"4956_CR5","doi-asserted-by":"publisher","first-page":"287","DOI":"10.7326\/M20-2496","volume":"173","author":"AV Hernandez","year":"2020","unstructured":"Hernandez AV, Roman YM, Pasupuleti V et al (2020) Hydroxychloroquine or chloroquine for treatment or prophylaxis of COVID-19: a living systematic review. Ann Intern Med. 173(4):287\u2013296","journal-title":"Ann Intern Med."},{"issue":"2","key":"4956_CR6","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/cpt.1844","volume":"108","author":"YX Du","year":"2020","unstructured":"Du YX, Chen XP (2020) Favipiravir: pharmacokinetics and concerns about clinical trials for 2019-nCoV infection. Clin Pharmacol Ther 108(2):242\u2013247","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"4956_CR7","doi-asserted-by":"publisher","first-page":"e039730","DOI":"10.1136\/bmjopen-2020-039730","volume":"10","author":"M Arab-Zozani","year":"2020","unstructured":"Arab-Zozani M, Hassanipour S, Ghoddoosi-Nejad D (2020) Favipiravir for treating patients with novel coronavirus (COVID-19): protocol for a systematic review and meta-analysis of randomised clinical trials. BMJ Open. 10(7):e039730","journal-title":"BMJ Open."},{"issue":"45","key":"4956_CR8","doi-asserted-by":"publisher","first-page":"11613","DOI":"10.1073\/pnas.1811345115","volume":"115","author":"DH Goldhill","year":"2018","unstructured":"Goldhill DH, Te Velthuis AJ, Fletcher RA et al (2018) The mechanism of resistance to favipiravir in influenza. Proc Natl Acad Sci 115(45):11613\u201311618","journal-title":"Proc Natl Acad Sci"},{"key":"4956_CR9","doi-asserted-by":"publisher","DOI":"10.1177\/2472555220942123","author":"W Zhu","year":"2020","unstructured":"Zhu W, Chen CZ, Gorshkov K et al (2020) RNA-dependent RNA polymerase as a target for COVID-19 Drug discovery. SLAS DISCOV Adv Sci Drug Discov. https:\/\/doi.org\/10.1177\/2472555220942123","journal-title":"SLAS DISCOV Adv Sci Drug Discov"},{"key":"4956_CR10","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1761882","author":"AA Elfiky","year":"2020","unstructured":"Elfiky AA (2020) SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1761882","journal-title":"J Biomol Struct Dyn"},{"key":"4956_CR11","doi-asserted-by":"publisher","DOI":"10.2174\/1871526520666200520112848","author":"AA Mohamed","year":"2020","unstructured":"Mohamed AA, Mohamed N, Mohamoud S et al (2020) SARS-CoV-2: the path of prevention and control. Infect Disord Drug Targets. https:\/\/doi.org\/10.2174\/1871526520666200520112848 (Online ahead of print)","journal-title":"Infect Disord Drug Targets"},{"issue":"5","key":"4956_CR12","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1007\/s12072-020-10072-8","volume":"14","author":"SK Sarin","year":"2020","unstructured":"Sarin SK, Choudhury A, Lau GK et al (2020) Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; the APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study). Hepatol Int 14(5):690\u2013700. https:\/\/doi.org\/10.1007\/s12072-020-10072-8","journal-title":"Hepatol Int"},{"key":"4956_CR13","doi-asserted-by":"publisher","DOI":"10.2174\/1871526520666200726224802","author":"S Abd-Elsalam","year":"2020","unstructured":"Abd-Elsalam S, Elkadeem M, Glal KA (2020) Chloroquine as chemoprophylaxis for COVID-19: Will this work? Infect Disord Drug Targets. https:\/\/doi.org\/10.2174\/1871526520666200726224802 (Online ahead of print)","journal-title":"Infect Disord Drug Targets."},{"key":"4956_CR14","doi-asserted-by":"publisher","DOI":"10.2174\/1871530320999201117142305","author":"S Abd-Elsalam","year":"2020","unstructured":"Abd-Elsalam S, Esmail ES, Khalaf M et al (2020) Tanta protocol for management of COVID-19. Perspectives from a developing country. Endocr Metab Immune Disord Drug Targets. https:\/\/doi.org\/10.2174\/1871530320999201117142305 (Online ahead of print)","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"4956_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.03.071","author":"M Xie","year":"2020","unstructured":"Xie M, Chen Q (2020) Insight into 2019 novel coronavirus\u2014an updated intrim review and lessons from SARS-CoV and MERS-CoV. Int J Infect Dis. https:\/\/doi.org\/10.1016\/j.ijid.2020.03.071 ([Epub ahead of print])","journal-title":"Int J Infect Dis"},{"key":"4956_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.09.024","author":"T Marjot","year":"2020","unstructured":"Marjot T, Moon AM, Cook JA et al (2020) Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study. J Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2020.09.024 (Online ahead of print. PMID: 33035628)","journal-title":"J Hepatol"},{"key":"4956_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.eng.2020.03.007","author":"Q Cai","year":"2020","unstructured":"Cai Q, Yang M, Liu D et al (2020) Experimental treatment with favipiravir for COVID-19: an open-label control study. Engineering (Beijing). https:\/\/doi.org\/10.1016\/j.eng.2020.03.007 ([Epub ahead of print])","journal-title":"Engineering (Beijing)"},{"key":"4956_CR18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang A-G et al (2007) A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175\u2013191","journal-title":"Behav Res Methods"},{"key":"4956_CR19","unstructured":"World Health Organization. Coronavirus disease (COVID-19) situation report\u2014139. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200607-covid-19-sitrep-139.pdf?sfvrsn=79dc6d08_2. Accessed 8 June 2020."},{"key":"4956_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.antiviral.2014.02.014","volume":"105","author":"L Oestereich","year":"2014","unstructured":"Oestereich L, L\u00fcdtke A, Wurr S et al (2014) Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model. Antiviral Res 105:17\u201321","journal-title":"Antiviral Res"},{"key":"4956_CR21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.antiviral.2015.08.015","volume":"123","author":"V Madelain","year":"2015","unstructured":"Madelain V, Oestereich L, Graw F et al (2015) Ebola virus dynamics in mice treated with favipiravir. Antiviral Res 123:70\u201377","journal-title":"Antiviral Res"},{"key":"4956_CR22","unstructured":"Noda A, Shirai T, Nakajima H et al (2020) Case report: two cases of COVID-19 pneumonia including use of favipiravir. The Japanese Association for Infectious Diseases. http:\/\/www.kansensho.or.jp\/uploads\/files\/topics\/2019ncov\/covid19_casereport_en_200408_2.pdf"},{"key":"4956_CR23","unstructured":"Yokoyama K, Oguri T, Kato A et al (2020) Case report a case of COVID-19 pneumonia that did not worsen and was relieved by early administration of favipiravir and ciclesonide. http:\/\/www.kansensho.or.jp\/uploads\/files\/topics\/2019ncov\/covid19_casereport_en_200406.pdf."},{"key":"4956_CR24","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.4269\/ajtmh.20-0290","volume":"102","author":"PM Abena","year":"2020","unstructured":"Abena PM et al (2020) Chloroquine and hydroxychloroquine for the prevention or treatment of COVID-19 in Africa: caution for inappropriate off-label use in healthcare settings. Am J Trop Med Hyg 102:1184\u20131188","journal-title":"Am J Trop Med Hyg"},{"key":"4956_CR25","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1128\/AAC.49.3.981-986.2005","volume":"49","author":"Y Furuta","year":"2005","unstructured":"Furuta Y et al (2005) Mechanism of action of T-705 against influenza virus. Antimicrob Agents Chemother. 49:981\u2013986","journal-title":"Antimicrob Agents Chemother."},{"issue":"5","key":"4956_CR26","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/cts.12827","volume":"13","author":"K Irie","year":"2020","unstructured":"Irie K, Nakagawa A, Fujita H et al (2020) Pharmacokinetics of favipiravir in critically Ill patients with COVID-19. Clin Transl Sci. 13(5):880\u2013885","journal-title":"Clin Transl Sci."},{"key":"4956_CR27","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/s13054-020-03078-z","volume":"24","author":"K Doi","year":"2020","unstructured":"Doi K, Ikeda M, Hayase N et al (2020) Nafamostat mesylate treatment incombination with favipiravir for patients critically ill with Covid-19: a case series. Crit Care 24:392","journal-title":"Crit Care"},{"key":"4956_CR28","first-page":"101200","volume":"31","author":"H Inoue","year":"2020","unstructured":"Inoue H, Jinno M, Ohta S et al (2020) Combination treatment of short-course systemic corticosteroid and favipiravir in a successfully treated case of critically ill COVID-19 pneumonia with COPD. Respir Med Case Rep 31:101200","journal-title":"Respir Med Case Rep"}],"updated-by":[{"DOI":"10.1007\/s00705-021-05307-4","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000},"record-id":"34201"},{"DOI":"10.1007\/s00705-021-04956-9","type":"expression_of_concern","label":"Expression of concern","source":"retraction-watch","updated":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:00Z","timestamp":1627948800000},"record-id":"34202"},{"DOI":"10.1007\/s00705-021-04956-9","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000}},{"DOI":"10.1007\/s00705-021-05307-4","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000}}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-021-04956-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00705-021-04956-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-021-04956-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T12:15:20Z","timestamp":1772021720000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00705-021-04956-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,25]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["4956"],"URL":"https:\/\/doi.org\/10.1007\/s00705-021-04956-9","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,25]]},"assertion":[{"value":"14 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2021","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Clarification","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Editor's Note:The Editor-in-Chief is currently investigating this article as concerns have been raised about the reporting of this clinical trial. Further editorial action will be taken as appropriate once the investigation into the concerns is complete and all parties have been given an opportunity to respond in full.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2021","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00705-021-05307-4","URL":"https:\/\/doi.org\/10.1007\/s00705-021-05307-4","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"There are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}